Blackstone, Baring in race to acquire up to 20% stake in Cipla

In one of the largest potential transactions this year, private-equity majors Blackstone and Baring have initiated talks with the Hamied family, the promoters of pharmaceutical firm Cipla, to......

SC asks Andhra court to decide on Ranbaxy-Sun Pharma merger

The Supreme Court on Wednesday asked the Andhra Pradesh High Court, which had passed an interim order staying the $ 4 billion merger of Ranbaxy with Sun Pharma, to decide the issue within two......

Sun Pharma has all the reasons to cheer Ranbaxy deal

There is a global movement towards generics and every patent-driven company wants a piece of the action, says Bhupesh Bhandari. In Sun Pharma's acquisition of Ranbaxy, what seems to have caught......

Sun Pharma-Ranbaxy deal may come under Sebi lens

The capital markets regulator, Securities and Exchange Board of India, is likely to begin a preliminary inquiry into the $4-billion merger deal between pharma giants Sun Pharmaceutical and Ranbaxy......